Pfizer In Two-Front Battle To Defend Product-Line Amid Merger Talks
Executive Summary
Speculation about potential mergers involving Monsanto may raise the stakes for Pfizer in its bid to acquire Warner-Lambert.
You may also be interested in...
Pfizer Expects Menstrually-Associated Migraine Claim For Relpax
Pfizer expects Relpax (eletriptan) to be the first triptan to receive a labeling claim for relief of menstrually-associated migraines.
Pfizer Expects Menstrually-Associated Migraine Claim For Relpax
Pfizer expects Relpax (eletriptan) to be the first triptan to receive a labeling claim for relief of menstrually-associated migraines.
Warner-Lambert And AHP Plan Protonix Copromotion Agreement
Warner-Lambert and American Home Products intend to complete a co-promotion agreement for AHP's proton pump inhibitor Protonix.